{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:57:10Z","timestamp":1762541830219},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T00:00:00Z","timestamp":1249948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s11033-009-9674-4","type":"journal-article","created":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T08:32:44Z","timestamp":1249893164000},"page":"269-272","source":"Crossref","is-referenced-by-count":11,"title":["Relationship between functional promoter polymorphism in the XBP1 gene (\u2212116C\/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia"],"prefix":"10.1007","volume":"37","author":[{"given":"Erkan","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fc\u00e7han","family":"Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap T\u0131ra\u015f","family":"Eker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclhis","family":"Deda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yekbun","family":"Adiguzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat","family":"Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,11]]},"reference":[{"issue":"3","key":"9674_CR1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.cdd.4401840","volume":"13","author":"J Wu","year":"2006","unstructured":"Wu J, Kaufman RJ (2006) From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ 13(3):374\u2013384","journal-title":"Cell Death Differ"},{"issue":"14","key":"9674_CR2","doi-asserted-by":"crossref","first-page":"R518","DOI":"10.1016\/S0960-9822(00)00583-2","volume":"10","author":"RY Hampton","year":"2000","unstructured":"Hampton RY (2000) ER stress response: getting the UPR hand on misfolded proteins. Curr Biol 10(14):R518\u2013R521","journal-title":"Curr Biol"},{"key":"9674_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.cellbio.18.011402.160624","volume":"18","author":"HP Harding","year":"2002","unstructured":"Harding HP, Calfon M, Urano F, Novoa I, Ron D (2002) Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 18:575\u2013599","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"9674_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80855-7","volume":"101","author":"K Mori","year":"2000","unstructured":"Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101(5):451\u2013454","journal-title":"Cell"},{"issue":"4","key":"9674_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","volume":"11","author":"S Oyadomari","year":"2004","unstructured":"Oyadomari S, Mori M (2004) Roles of CHOP\/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11(4):381\u2013389","journal-title":"Cell Death Differ"},{"issue":"5695","key":"9674_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306(5695):457\u2013461","journal-title":"Science"},{"key":"9674_CR7","doi-asserted-by":"crossref","unstructured":"Paschen W (2004) The organelles, II: endoplasmic reticulum and its overload. In: Herdegen T, Delgado-Garcia JM (eds) Brain damage and repair, Chap 8. Kluwer, Netherlands","DOI":"10.1007\/1-4020-2541-6_8"},{"issue":"Suppl 3","key":"9674_CR8","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.2337\/diabetes.51.2007.S455","volume":"51","author":"HP Harding","year":"2002","unstructured":"Harding HP, Ron D (2002) Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51(Suppl 3):S455\u2013S461","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"9674_CR9","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.cdd.4401468","volume":"11","author":"M Vasa-Nicotera","year":"2004","unstructured":"Vasa-Nicotera M (2004) The new kid on the block: the unfolded protein response in the pathogenesis of atherosclerosis. Cell Death Differ 11(Suppl 1):S10\u2013S11","journal-title":"Cell Death Differ"},{"issue":"12","key":"9674_CR10","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00125-007-0816-8","volume":"50","author":"P Marchetti","year":"2007","unstructured":"Marchetti P, Bugliani M, Lupi R, Marselli L, Masini M, Boggi U, Filipponi F, Weir GC, Eizirik DL, Cnop M (2007) The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50(12):2486\u20132494","journal-title":"Diabetologia"},{"issue":"5790","key":"9674_CR11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","volume":"313","author":"U Ozcan","year":"2006","unstructured":"Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Gorgun CZ, Hotamisligil GS (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313(5790):1137\u20131140","journal-title":"Science"},{"key":"9674_CR12","doi-asserted-by":"crossref","unstructured":"Yilmaz E, Berberoglu M, Akar N (2008) Relationship between functional promoter polymorphism in the XBP1 gene (\u2212116C\/G) and obesity. Clin Appl Thromb Hemost. doi: 10.1177\/1076029608323498","DOI":"10.1177\/1076029608323498"},{"issue":"7121","key":"9674_CR13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860\u2013867","journal-title":"Nature"},{"key":"9674_CR14","unstructured":"Zeng L, Zampetaki A, Margariti A, Li H, Xiao Q, Hu Y, Xu Q (2007) Abstract 1294: XBP1 is a key protein inducing endothelial cell death in vivo and in vitro. Circulation 116(16_MeetingAbstracts):II_264-b-"},{"key":"9674_CR15","unstructured":"Colgan SM, Jacobsen DW, Austin RC (2006) In: Cheema SK (ed) Biochemistry of atherosclerosis. Springer, Newyork"},{"issue":"6","key":"9674_CR16","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1055\/s-0038-1665446","volume":"78","author":"N Akar","year":"1997","unstructured":"Akar N, Akar E, Dalgin G, Sozuoz A, Omurlu K, Cin S (1997) Frequency of Factor V (1691 G\u2013> A) mutation in Turkish population. Thromb Haemost 78(6):1527\u20131528","journal-title":"Thromb Haemost"},{"issue":"2","key":"9674_CR17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-8652(200002)63:2<102::AID-AJH10>3.0.CO;2-R","volume":"63","author":"N Akar","year":"2000","unstructured":"Akar N, Akar E, Yilmaz E (2000) Factor V (His 1299 Arg) in Turkish patients with venous thromboembolism. Am J Hematol 63(2):102\u2013103","journal-title":"Am J Hematol"},{"issue":"3","key":"9674_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-8652(199807)58:3<249::AID-AJH20>3.0.CO;2-3","volume":"58","author":"N Akar","year":"1998","unstructured":"Akar N, Misirlioglu M, Akar E, Avcu F, Yalcin A, Sozuoz A (1998) Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 58(3):249","journal-title":"Am J Hematol"},{"issue":"3","key":"9674_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0049-3848(00)00310-8","volume":"100","author":"F Avcu","year":"2000","unstructured":"Avcu F, Akar E, Demirkilic U, Yilmaz E, Akar N, Yalcin A (2000) The role of prothrombotic mutations in patients with Buerger\u2019s disease. Thromb Res 100(3):143\u2013147","journal-title":"Thromb Res"},{"key":"9674_CR20","unstructured":"Preacher KJ (2001) Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence\u2014computer software. Available from http:\/\/www.quantspy.org"},{"key":"9674_CR21","volume-title":"Statistical methods in medical research","author":"G Armitage PaB","year":"1994","unstructured":"Armitage PaB G (1994) Statistical methods in medical research. Blackwell, London"},{"issue":"2","key":"9674_CR22","first-page":"245","volume":"19","author":"N Akar","year":"2002","unstructured":"Akar N (2002) Molecular approach to Turkish pediatric stroke patients. Turk J Haematol 19(2):245\u2013253","journal-title":"Turk J Haematol"},{"issue":"1","key":"9674_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1160\/TH04-09-0560","volume":"93","author":"ML Goor van","year":"2005","unstructured":"van Goor ML, Garcia EG, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D (2005) The plasminogen activator inhibitor (PAI-1) 4G\/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study. Thromb Haemost 93(1):92\u201396","journal-title":"Thromb Haemost"},{"issue":"4","key":"9674_CR24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/088307380101600413","volume":"16","author":"N Akar","year":"2001","unstructured":"Akar N, Akar E, Yilmaz E, Deda G (2001) Plasminogen activator inhibitor-1 4G\/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. J Child Neurol 16(4):294\u2013295","journal-title":"J Child Neurol"},{"issue":"2","key":"9674_CR25","first-page":"83","volume":"21","author":"E Yilmaz","year":"2004","unstructured":"Yilmaz E, Akar E, Akar N (2004) Effect of plasminogen activator inhibitor-1 4G\/5G polymorphism in Turkish deep vein thromboembolic patients with and without prothrombin 20210 G-A. Turk J Haematol 21(2):83\u201386","journal-title":"Turk J Haematol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-009-9674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-009-9674-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-009-9674-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T09:06:10Z","timestamp":1590051970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-009-9674-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["9674"],"URL":"https:\/\/doi.org\/10.1007\/s11033-009-9674-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,11]]}}}